Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2014-09-19 Report Publication Anno…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Annual Financial Report
Report Publication Announcement Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 1753S' and 'This information is provided by RNS'). The core purpose of this short announcement is to state that the 'Annual Report and Accounts for the year ended 30 June 2014, Notice of Annual General Meeting and Proxy Form have now been mailed to shareholders' and submitted to the National Storage Mechanism. According to Rule 2 ('THE "MENU VS MEAL" RULE'), when a document announces that a report has been published or mailed, and the document itself is short (2173 chars), it should be classified as a Report Publication Announcement (RPA), not the full report (10-K or AR).
2014-09-19 English
Notice of 2014 AGM
AGM Information Classification · 100% confidence The document is explicitly titled "Annual General Meeting 2014" and contains a "Chairman's Letter and Notice of Annual General Meeting." It details numerous resolutions (1 through 17) that shareholders are asked to vote on at the meeting scheduled for October 24, 2014. These resolutions cover receiving the Annual Report, approving the Remuneration Report/Policy, dividend approval, director re-elections, auditor re-appointment, and authorities for share allotment and purchase. This content is the core material distributed to shareholders in preparation for the AGM, which aligns perfectly with the definition of AGM Information (AGM-R). Although it references the Annual Report (10-K) and Remuneration Report (DEF 14A), the document's primary function is to serve as the notice and accompanying materials for the meeting itself.
2014-09-19 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an official announcement filed via RNS (RNS Number : 7212R) dated September 15, 2014. The content explicitly details share transactions (granting of nil cost options) involving Directors and Persons Discharging Managerial Responsibilities (PDMRs) under an incentive plan. This directly matches the definition for Director's Dealing (insider trades by executives). The filing type code DIRS is appropriate.
2014-09-15 English
Block Listing Six Monthly Return
Remuneration Information Classification · 99% confidence The document is explicitly labeled with "RNS Number : 6869R" and contains multiple sections titled "BLOCK LISTING SIX MONTHLY RETURN". This format, along with the RNS identifier and the nature of the data (reporting on unallotted securities under various schemes over a six-month period), strongly indicates a standard regulatory filing disseminated through the London Stock Exchange's Regulatory News Service (RNS). Since this is a specific regulatory disclosure that doesn't fit the definitions for 10-K, ER, IR, or DIRS, the most appropriate general category for a standard regulatory announcement is RNS.
2014-09-15 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an RNS announcement (RNS Number : 5863R) dated September 12, 2014. The content explicitly details the 'Director / PDMR shareholding' activity, specifically the 'Exercise of LTIP options' by a Director (Ian Page) and a PDMR (Zoe Goulding), including the number of options exercised, shares sold to cover tax, and resulting total shareholdings. This directly matches the definition of Director's Dealing (insider trades by executives). Therefore, the correct classification is DIRS.
2014-09-12 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an official announcement filed via RNS (RNS Number : 4684R) dated September 11, 2014. The content explicitly details a transaction involving shares by a company director (Chief Financial Officer, Anne-Francoise Nesmes), including the exercise of options and subsequent sale of shares to cover tax liabilities, along with the resulting total shareholding percentage. This directly matches the definition of Director's Dealing (insider trades). Therefore, the appropriate code is DIRS.
2014-09-11 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.